Advances in mesenchymal stem cells combined with traditional Chinese medicine therapy for liver fibrosis / 中西医结合学报
Journal of Integrative Medicine
; (12): 147-155, 2014.
Article
en En
| WPRIM
| ID: wpr-308201
Biblioteca responsable:
WPRO
ABSTRACT
Liver fibrosis is a primary cause of liver cirrhosis, and even hepatocarcinoma. Recently, the usage of mesenchymal stem cells (MSCs) has been investigated to improve liver fibrosis. It has been reported that the differentiation, proliferation and migration of MSCs can be regulated by traditional Chinese medicine treatment; however, the mechanisms are still unclear. In this article, the authors review the characteristics of MSCs such as multidirectional differentiation and homing, and its application in animal experiments and clinical trials. The authors also list areas that need further investigation, andlook at the future prospects of clinical application of MSCs.
Texto completo:
1
Bases de datos:
WPRIM
Medicinas Tradicionales:
Medicinas_tradicionales_de_asia
/
Medicina_china
Asunto principal:
Fisiología
/
Terapéutica
/
Diferenciación Celular
/
Movimiento Celular
/
Ensayos Clínicos como Asunto
/
Terapia Combinada
/
Biología Celular
/
Trasplante de Células Madre Mesenquimatosas
/
Células Madre Mesenquimatosas
/
Cirrosis Hepática
Tipo de estudio:
Diagnostic_studies
Idioma:
En
Revista:
Journal of Integrative Medicine
Año:
2014
Tipo del documento:
Article